TheraRadar
← Back
Data updated: Jun 17, 2026

IVAX PHARMS INC

Generics
Pharmaceuticals

IVAX PHARMS INC is a generic drug manufacturer with 26 FDA-approved products.

1977
Since
26
Drugs
-
Trials
0
New Drugs (2yr)
Modality:

IVAX PHARMS INC's Key Drugs

IVAX PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

IVAX PHARMS INC's Recent FDA Approvals

New NDA/BLA approvals for IVAX PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

IVAX PHARMS INC's Therapeutic Areas

Disease areas where IVAX PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

IVAX PHARMS INC Pipeline Snapshot

Active clinical trials for IVAX PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling